Immunocellular Therapeutics, Ltd. (IMUC) Posts Break Even Q4 Loss
Immunocellular Therapeutics, Ltd. (NYSE: IMUC) reported Q4 ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
